Covid 19 Information
A section dedicated to information on pharmacovigilance of medicinal products used to treat and prevent COVID-19 (coronavirus).
The section is divided into two parts: one part relating to links to national and international institutional websites on SARS-CoV-2 (COVID-19) and another part relating to important research documents and initiatives from ISoP members and others.
This page will be regularly updated.
ISoP Member Papers and initiatives
ISoP colleagues in the North American Chapter of ISoP (NASoP) and the Italian Society of Pharmacology (SIF) are working on proposals to monitor the safety of medicines and vaccines to treat and prevent COVID-19. Here you will find also important research documents and initiatives from ISoP members and others.
The contents of this page are intended for purely informational purposes (the list is not exhaustive). Updated Jan 2022.